SIMULANDS

Simulands is a medical simulation company founded in 2019 by a diverse team of engineers, entrepreneurs, clinicians, and industry professionals. The company specializes in developing human-grade cardiovascular simulators aimed at enhancing research and education in structural heart interventions. Their simulators provide practical, cost-effective, and ethical training solutions that utilize real medical devices and imaging, ensuring a realistic procedural experience. The core mission of Simulands is to shift away from traditional patient and animal testing by offering simulation platforms that comply with ISO standards. Their products are designed for hands-on training, education, certification, and re-certification, making them a comprehensive educational tool. Simulands emphasizes high-quality manufacturing and innovation, ensuring that their simulators meet medical device regulations and are suitable for both educational and R&D purposes. Targeting physicians, medical educators, researchers, and structural heart intervention teams, Simulands aims to improve patient safety and procedural outcomes through advanced simulation tools. Their solutions support a wide range of training needs in the cardiovascular field, promoting a more ethical approach to medical education.

• Employees 14
• Founded 2019
• Annual Revenue $3000000
• Total Funding $10637700